A benzodiazepine activator locks Kv7.1 channels open by electro-mechanical uncoupling.

Schreiber JA; Möller M; Zaydman M; Zhao L; Beller Z; Becker S; Ritter N; Hou P; Shi J; Silva J; Wrobel E; Strutz-Seebohm N; Decher N; Schmitt N; Meuth SG; Düfer M; Wünsch B; Cui J; Seebohm G

Research article (journal) | Peer reviewed

Abstract

Loss-of-function mutations in Kv7.1 often lead to long QT syndrome (LQTS), a cardiac repolarization disorder associated with arrhythmia and subsequent sudden cardiac death. The discovery of agonistic IKs modulators may offer a new potential strategy in pharmacological treatment of this disorder. The benzodiazepine derivative (R)-L3 potently activates Kv7.1 channels and shortens action potential duration, thus may represent a starting point for drug development. However, the molecular mechanisms underlying modulation by (R)-L3 are still unknown. By combining alanine scanning mutagenesis, non-canonical amino acid incorporation, voltage-clamp electrophysiology and fluorometry, and in silico protein modelling, we show that (R)-L3 not only stimulates currents by allosteric modulation of the pore domain but also alters the kinetics independently from the pore domain effects. We identify novel (R)-L3-interacting key residues in the lower S4-segment of Kv7.1 and observed an uncoupling of the outer S4 segment with the inner S5, S6 and selectivity filter segments.

Details about the publication

JournalCommunications biology (Commun Biol)
Volume5
Issue1
Page range301-301
StatusPublished
Release year2022 (01/04/2022)
Language in which the publication is writtenEnglish
DOI10.1038/s42003-022-03229-8
Link to the full texthttps://pmc.ncbi.nlm.nih.gov/articles/PMC8976019/
KeywordsBenzodiazepines; Ion Channel Gating; Mutation

Authors from the University of Münster

Becker, Sebastian
Department for Cardiovascular Medicine
Düfer, Martina
Professur für Pharmakologie und Toxikologie (Prof. Düfer)
Möller, Melina
Department for Cardiovascular Medicine
Ritter, Nadine
Institut für Genetik von Herzerkrankungen (IfGH)
Schreiber, Julian Alexander
Professur für Pharmazeutische Chemie (Prof. Wünsch)
Independent Junior Research Group Julian Schreiber
Seebohm, Guiscard
Institut für Genetik von Herzerkrankungen (IfGH)
Strutz-Seebohm, Nathalie
Institut für Genetik von Herzerkrankungen (IfGH)
Wrobel, Eva
Department for Cardiovascular Medicine
Wünsch, Bernhard
Professur für Pharmazeutische Chemie (Prof. Wünsch)